The phamaceutical giant continues to defend the product’s safety, but says demand for the talc-based powder is declining
Pharmaceutical giant Johnson & Johnson on Tuesday said it would stop selling its talcum-based Johnson’s baby powder in the United States and Canada as part of a broad reassessment of its consumer product portfolio.
J&J has faced tens of thousands of lawsuits from consumers claiming its talc products, including the instantly recognizable brand of Johnson’s Baby Powder, caused their cancer, but J&J said it remains confident in the product’s safety and intends to continue to defend its goods in the courtroom.
